Share Name Share Symbol Market Type Share ISIN Share Description
Fastfwd Innov LSE:FFWD London Ordinary Share GG00BRK9BQ81 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.625p -4.31% 13.875p 13.75p 14.00p 14.625p 13.875p 14.50p 848,142 15:58:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 3.8 2.9 4.8 23.16

Fastfwd Innov Share Discussion Threads

Showing 9201 to 9223 of 9225 messages
Chat Pages: 369  368  367  366  365  364  363  362  361  360  359  358  Older
DateSubjectAuthorDiscuss
11/8/2018
20:11
Next investment in cannabis will be Ceres Coin
jonesyboy 27
11/8/2018
18:27
market Cap appears to have jumped a lot, now £24m. I understand that the new shares will have been been issued but was not expecting such dilution -think the MCap was £13m a month ago, maybe not? We must be at a good premium to NAV at this price now
kristini2
11/8/2018
00:20
A good end to the week UP 8.5%.
888icb
10/8/2018
13:05
Agreed. This is going to get quite exciting in the near term imo. Load up whilst mkt is quiet & peeps on hols!
bobby1904
10/8/2018
09:47
Yes 888, good to see this heading in the right direction. Still greatly undervalued here in my view. I think we will get news before long that will take us way above this level, it's just a question of time now.That news could be from any one of our investees, e.g. Factom, Vemo, Leap, Intensity, Juvenescence, etc, or maybe a new cannabis investment. Many possibilities for next news. There have been several hints of an upcoming pot stock investment, e.g. EMMAC? Imagine what that would do to the share price
bdog51
10/8/2018
09:37
Ticking up this morning. Currently UP 3.7% on volume of 260000.
888icb
09/8/2018
18:37
Evening monkeymonkey, was not a dig at you was just stating all out there to see.We will be fine here.
thelogman
09/8/2018
09:25
well nothing happening on here and nothing happening with FFWD, as they said all action could or should be known by end of september, so for now were in no man's land, enjoy the wait lol,
monkeymonkey
09/8/2018
08:06
morning logman ur right nothing new it was on the crypto site just thought they had put the article together quite well that's all, FFWD needs airtime so every bit helps, my only worry now is hows the FCT funding going, i hope FFWD early investment wasn't just to keep FCT going ? but a stroke of genius
monkeymonkey
08/8/2018
22:00
Good night,can not be bothered go lse and listen to rubbish.Ffwd will do us all good no probs.
thelogman
08/8/2018
21:58
They were not big buys as richthenewbie says, absolute obvious to anyone who as aim knowledge.
thelogman
08/8/2018
21:58
It is a site that is quite interesting. Sure the investment is already known....what's the problem?
hazl
08/8/2018
15:08
good find monkey...
hazl
08/8/2018
08:30
https://www.bankingtech.com/2018/08/blockchain-record-tracker-factom-gets-6m-investment/ Blockchain record-tracking company Factom is taking a $6 million investment from an investment firm that’s traded on a submarket of the London Stock Exchange (LSE), reports Xconomy (FinTech Fututes’ sister publication). FastForward Innovations has created what’s known as a Simple Agreement for Future Equity (sometimes called a SAFE note) to invest the $6 million in Factom, which was founded in Austin, Texas in 2015. Under the terms of the deal, FastForward’s investment gets converted into shares of Factom’s Series B round of Funding at a 25% discount. Factom has proposed the round, but hasn’t announced the terms of yet, according to FastForward. Additionally, FastForward has the option to invest as much as $9 million more on the same terms by 30 September, according to a release filed with the LSE. FastForward invests in early stage businesses and trades on the LSE’s Alternative Investment Market (AIM), which is focused on smaller growing companies, according to the LSE. Factom plans to use the funds to build out and scale its Software-as-a-Service platform. The company also plans to expand its roadmap for products, expand its sales and marketing teams, and invest in other operations. Factom also planned to use the funding to expand its patent portfolio to more than 20 from 14 – which it has already started doing. The company filed a patent related to verifying documents on a blockchain, around the same time that other corporate giants like Walmart and IBM filed other blockchain-related patents. Factom uses blockchain technology to secure and verify data such as public records and business documents, giving large and small businesses and government organisations access to a system that maintains permanent, time-stamped records and data. The company is still generating its full revenue model, but says it has worked with numerous firms, including those in the banking, financial services and insurance industries, as well as government entities, such as the US Department of Homeland Security. FastForward said Factom had gross assets of $1.4 million as of 30 March, and reported a loss of $4.7 million in 2017. Factom closed its Series A round of funding in 2017 at about $8 million. It was led by Tim Draper, the noted venture capitalist who runs investment firm Draper Associates. Peeli Ventures, Harvest Equity, and a group of local Austin investors also participated. Other than Factom, FastForward lists seven investments on its website, including a 3D gaming company called Leap Gaming and a cancer immunotherapy company called Intensity Therapeutics. The $6 million investment in Factom is FastForward’s largest investment to date, the company says. In fact, FastForward said it borrowed $800,000 from its CEO, Lorne Abony, in order to secure the deal with Factom. FastForward is headquartered in the Bailiwick of Guernsey, a crown dependency of the UK. It was previously known as Kuala Innovations. In 2006, Abony sold a company he co-founded called Fun Technologies, which was traded on the Toronto Stock Exchange, for CA$484 million ($415 million).
monkeymonkey
06/8/2018
20:18
Listen to loggy, get your money in here, big gains to be had, loggy is a cash machine.21 days you are in big profits, loggy has been emailed.Make of it what you will.Told peeps it was gonna spike last time, i,m telling you now this is gonna spike, you rather believe or you don,t.
thelogman
06/8/2018
20:12
Jim's kept DBC alive, you think he cares about small investors? -he's a ruthless businessman and very successful, you don't make Jim's money by being a socialist thinking chap, sorry but i fear we'll be stuffed, time will tell if the business works
kristini2
06/8/2018
19:44
kristini2,I am a direct investor in DBC too :-( Jim Mellon was encouraging people to invest in DBC at the Master Investor Shows, I get his loans kept the business afloat but he needs to play fair by small shareholders. I think its a question of trust, will Jim Mellon do the right thing? Lets be honest most investors have invested because of Jim Mellon pumping it and his expertise in this field. It's not been a good investment lets hope it come right soon.
adred
06/8/2018
17:12
problem with DBC is that Jim has a convertible loan note to DBC which kept the business afloat, when this converts to equity existing shareholders may get diluted out ..... i'm a direct investor in DBC as well as in ffwd
kristini2
06/8/2018
12:37
Update on DBC ; 23 July 2018 The team at PulseFlow Technologies continue to make a positive impact in the wound healing arena, connecting global medical Distributors with exceptional opportunities. In-house developments earlier this year saw the appointment of Dan Blackman as COO. A qualified experienced Podiatrist and clinical lead specialist makes Dan ideally placed to oversee operations for the advancement of PFDF. Alongside developing PFDF - our award-winning medical device for assisting Diabetic Foot Ulcer recovery, the broader potential of offering this device to Vascular Surgical teams is being developed for patients recovering from post-operative revascularisation surgery to ensure that presenting poor circulatory systems don’t delay healing and create poor patient outcomes. The larger category available to us increases clinical appeal without diluting our core product offer is a significant re focus and positive development. Dedicated specialists, partners and associates look to Stella Withy, PFT UK General Manager to answer commercial matters. The next half of 2018 will see us focus on establishing strong relationships in manufacturing and distribution channels. Interested in onboarding this innovative Class IIa medical device solution for lower limb issues in your portfolio?
adred
06/8/2018
12:10
Nice example Jonesy, thank you. I suspect that due to dubious motives some individuals will ignore the obvious and resort to scare mongering. That said, if you are swayed in your investment decisions by BB comments you probably shouldn't be investing in the first place!! Anyway, back to lurking :)
neutronium
06/8/2018
09:24
It’s a simple as this... FCT is to Factom as Nectar ponts are to Sainsburys...loosely linked but zero to do with factom.inc. Factom.org = FCT. WE ARE INVESTED IN FACTOM.INC. How difficult is it to understand?
jonesyboy 27
06/8/2018
09:15
That is so common neutronium....I have despaired at the lack of research and interest in APPS for example. They got finance from buyers at 70p a share...yet look at it now all because of a W i n n ifrith article. However great to see renewed interest here.
hazl
06/8/2018
08:56
Sigh - for the last time trendspotting - they did NOT invest in the coin, please do some research other than merely looking at the name
neutronium
Chat Pages: 369  368  367  366  365  364  363  362  361  360  359  358  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180815 01:09:11